PRMT5 and pulmonary fibrosis: Likewise, patients having experienced progression in lung fibrosis, determined by an increased involvement of semiquantified areas in high-resolution CT (HRCT) in the past 12 months, demonstrated a significant elevation in anti-PRMT5 antibody levels (figure 4E).